PDCO:NGS-Patterson Companies Inc. (USD)

EQUITY | Medical Distribution | Nasdaq Global Select

Last Closing

USD 27.79

Change

+0.75 (+2.77)%

Market Cap

USD 3.92B

Volume

0.43M

Analyst Target

USD 24.23
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Patterson Companies Inc is a distributors of dental products in North America. The Company operates in three business segments: dental supply, veterinary supply and rehabilitation supply.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
HSIC Henry Schein Inc

+0.31 (+0.43%)

USD 9.40B
ZYXI Zynex Inc

+0.27 (+2.47%)

USD 0.36B
EDAP EDAP TMS SA

-0.12 (-1.62%)

USD 0.27B
YI 111 Inc

+0.02 (+1.98%)

USD 0.09B
AHG Akso Health Group ADR

+0.03 (+3.71%)

USD 0.08B
COSM Cosmos Health Inc.

+0.13 (+25.75%)

USD 0.01B

ETFs Containing PDCO

KATZ:XETRA 7.02 % 0.00 %

N/A

N/A
PETZ:SW 7.02 % 0.00 %

N/A

N/A
PETZ:LSE 6.46 % 0.00 %

N/A

N/A
DIVY Reality Shares DIVS ETF 4.31 % 0.85 %

-0.03 (0%)

USD 0.01B
JPSV Jpmorgan Active Small Cap.. 1.33 % 0.00 %

+0.13 (+0%)

USD 0.02B
ROSC Hartford Multifactor Smal.. 0.98 % 0.00 %

+0.11 (+0%)

USD 0.03B
DGRS WisdomTree U.S. SmallCap .. 0.00 % 0.38 %

+0.14 (+0%)

USD 0.34B
RNSC First Trust Small Cap US .. 0.00 % 0.60 %

+0.16 (+0%)

USD 0.04B
DESD:LSE 0.00 % 0.00 %

N/A

N/A
DESE:LSE 0.00 % 0.00 %

N/A

N/A
WTEC:F 0.00 % 0.00 %

N/A

N/A
WTEC:XETRA 0.00 % 0.00 %

N/A

N/A
SDEI 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.32% 43% F 41% F
Dividend Return 0.91% 100% F 60% D-
Total Return -1.41% 43% F 42% F
Trailing 12 Months  
Capital Gain 5.63% 71% C- 59% D-
Dividend Return 3.95% 100% F 61% D-
Total Return 9.58% 86% B+ 62% D
Trailing 5 Years  
Capital Gain 27.19% 67% D+ 66% D+
Dividend Return 22.61% 100% F 84% B
Total Return 49.79% 67% D+ 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 13.20% 57% F 74% C
Dividend Return 17.17% 71% C- 77% C+
Total Return 3.97% 100% F 79% B-
Risk Return Profile  
Volatility (Standard Deviation) 34.24% 86% B+ 54% F
Risk Adjusted Return 50.14% 100% F 82% B
Market Capitalization 3.92B 86% B+ 82% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.40 100% 60%
Price/Book Ratio 2.51 71% 40%
Price / Cash Flow Ratio -3.24 71% 70%
Price/Free Cash Flow Ratio 8.36 43% 29%
Management Effectiveness  
Return on Equity 18.65% 100% 88%
Return on Invested Capital 13.23% 86% 83%
Return on Assets 5.96% 100% 88%
Debt to Equity Ratio 40.34% 50% 45%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector